| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
2e-06 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.28 |
3e-06 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-06 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-06 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |